Valued at USD 8.19 billion in 2024, the CBD oil market is projected to reach USD 9.22 billion in 2025 and USD 26.95 billion by 2034, growing at a CAGR of 12.7% during the forecast period 2025–2034. North America was the largest regional market in 2024. Growth reflects wider acceptance of cannabidiol-based products in therapeutic applications. Key players include Charlotte’s Web, CV Sciences, Medical Marijuana Inc., Isodiol International, Elixinol, Aurora Cannabis, Canopy Growth, Endoca, NuLeaf Naturals, Green Roads, Pure Kana, Lazarus Naturals, Joy Organics, Medterra, and Veritas Farms.

Wellness Demand Fuels Consumer Adoption

Consumers are increasingly seeking natural alternatives to pharmaceutical drugs, and many consider CBD wellness products part of a wellness regimen, citing reported benefits in reducing anxiety, improving sleep, and managing chronic pain. According to the American College of Physicians, around 20% of the US adult population experiences chronic pain, and a growing number of consumers turn to CBD as a supplementary option. This aligns with the inclination toward non-invasive, holistic, and preventive health solutions. Thus, rising demand for health and wellness products containing natural ingredients is expected to drive growth during the forecast period.

Legalization and Regulatory Support

Expanding legalization has had a significant impact, particularly in North America and parts of Europe. In the US, the 2018 Farm Bill decriminalized hemp-derived CBD at the federal level, spurring commercial interest. According to the European Industrial Hemp Association, more European countries are adopting policies to regulate CBD, broadening accessibility and allowing safer products to enter the market. Hemp-derived CBD holds the larger source share because its low THC content aligns with legal restrictions in the US and European Union nations. The widespread availability of hemp-derived CBD products in specialty and mainstream retail outlets further supports its share.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/cbd-oil-market

Marijuana-Derived Products and Therapeutic Use

Marijuana-derived CBD is expected to gain traction where medicinal or recreational use is legalized. These products, with higher THC content, are commonly used in therapeutic settings to address chronic pain and neurological disorders under medical guidance. Regulatory complexities persist, but favorable policies in certain markets are fostering R&D and consumer trust. In October 2024, Aurora Cannabis, with MedReleaf Australia, announced an enhanced range of premium medical cannabis oil in Australia.

Skincare and Personal Care Momentum

CBD-infused skincare has emerged as a significant segment, with brands incorporating CBD for its potential anti-inflammatory and antioxidant properties in creams, serums, and lotions. Personal care and cosmetics is the fastest-growing application, supported by demand for plant-based, sustainable products, particularly among younger consumers. As awareness of potential skincare benefits rises, the trend is expected to strengthen among consumers prioritizing natural and sustainable beauty. The pharma and nutraceuticals segment still holds the largest share, driven by interest in CBD for chronic pain, anxiety, and epilepsy.

Competitive Landscape

Competition is characterized by product diversification and quality focus. Many players offer full-spectrum CBD oil, broad-spectrum formulations, and isolated CBD. Charlotte’s Web and Green Roads prioritize traceability and potency, and Charlotte’s Web announced in June 2024 that its CBD oil were available at Walmart. Many companies are vertically integrated, controlling production from cultivation to distribution to support consistency and transparent sourcing. Companies are also investing in proprietary formulations and organic sourcing to appeal to health-conscious consumers.

Regional Outlook and Strategy

North America benefits from favorable frameworks and advanced retail infrastructure. Europe’s UK, Germany, and Switzerland lead consumption, while Asia Pacific is emerging, driven by Australia and Japan, though strict regulations limit acceptance. Side effects and safety concerns remain a restraint, so transparency through third-party lab testing and clear labeling is central to building consumer trust

More Trending Latest Reports By Polaris Market Research:

protein-bar-market

automotive-dashcam-market

natural-beta-carotene-market

graphene-market

electronic-design-automation-market

internet-of-things-iot-in-healthcare-market

organ-on-chip-market

fitness-equipment-market

us-smart-meter-market